Linagliptin Tablets for Diabetes (Trajenta)
Comprehensive guide to linagliptin (Trajenta) tablets: uses, dosage, side effects, and management of type 2 diabetes effectively.

Linagliptin, marketed as
Trajenta
, is a prescription medication designed to help managetype 2 diabetes
in adults. It belongs to a class of drugs calleddipeptidyl peptidase-4 (DPP-4) inhibitors
, which work by enhancing the body’s natural insulin response after meals to improve blood sugar control.About linagliptin tablets
Type 2 diabetes occurs when the pancreas does not produce enough insulin or the body cannot use it effectively, leading to elevated blood glucose levels.
Linagliptin
addresses this by blocking the DPP-4 enzyme, which normally breaks down incretin hormones. These hormones, such as GLP-1 and GIP, are released after eating and stimulate insulin production while suppressing glucagon—a hormone that raises blood sugar. By prolonging incretin action, linagliptin increases insulin when glucose is high and reduces liver glucose output, without causing low blood sugar when levels are normal.Trajenta tablets are typically 5 mg and taken once daily, with or without food. They are used alongside diet and exercise, and often combined with other antidiabetic drugs like metformin, sulfonylureas, or insulin when single therapies are insufficient.
Before taking linagliptin tablets
Allergy
Do not take linagliptin if you are allergic to it or any ingredients in Trajenta. Signs of allergy include rash, itching, swelling, severe dizziness, or trouble breathing—seek immediate medical help.
Pregnancy and breastfeeding
Linagliptin is not recommended during pregnancy due to limited data; consult your doctor for alternatives. It is unknown if it passes into breast milk, so discuss risks with your healthcare provider.
Other medicines, medical conditions, and driving
- Other medications: Inform your doctor about all drugs, especially those causing hypoglycemia like insulin or sulfonylureas, as combinations increase low blood sugar risk. No dose adjustments needed for renal impairment, unlike some DPP-4 inhibitors.
- Medical conditions: Safe for severe renal impairment or end-stage renal disease; no dosage change required. Use caution with heart failure history, pancreatitis, or liver issues.
- Driving: Hypoglycemia can impair concentration—monitor blood sugar and avoid driving if symptoms like dizziness occur.
How and when to take linagliptin tablets
Dosage
The standard dose is
one 5 mg tablet once daily
. No adjustments for age, kidney, or liver function. Take at the same time each day for consistency.Getting the most from your treatment
- Combine with a balanced diet low in sugars and regular exercise (e.g., 150 minutes weekly).
- Monitor blood glucose regularly; aim for HbA1c targets set by your doctor.
- Continue even if feeling well—diabetes management is long-term.
- Missed dose: Take as soon as remembered unless near next dose; do not double up.
| Indication | Dose | Frequency | Adjustments |
|---|---|---|---|
| Monotherapy | 5 mg | Once daily | None for renal/hepatic impairment |
| Combination therapy | 5 mg | Once daily | Monitor with sulfonylureas/insulin |
Side-effects
Most people tolerate linagliptin well. Common side effects are mild and often resolve.
| Side Effect | Description |
|---|---|
| Respiratory infections | Nasal congestion, sore throat |
| Cough | Usually temporary |
| Pancreatitis (rare but serious) | Severe abdominal pain radiating to back; stop and seek help |
Hypoglycemia: Rare alone (0.1-1%); higher risk (up to 30%) with insulin/sulfonylureas. Symptoms: sweating, trembling, hunger, confusion. Treat with glucose.
Serious risks: Pancreatitis, severe allergic reactions (anaphylaxis), joint pain, bullous pemphigoid (skin blisters). Report persistent severe joint pain or skin changes.
Common questions about linagliptin tablets
How long does linagliptin take to work?
Improvements in blood sugar seen within weeks; maximum HbA1c reduction (0.5-1%) in 3 months. Studies show significant HbA1c drops vs. placebo after 24 weeks.
Is linagliptin the same as sitagliptin?
No—both DPP-4 inhibitors, but linagliptin has no renal dose adjustment and primarily biliary excretion.
Can I take linagliptin with metformin?
Yes, commonly combined for better control when metformin alone insufficient.
Does linagliptin cause weight gain?
Weight-neutral; no significant gain or loss reported.
Can linagliptin cause pancreatitis?
Rare; symptoms include severe stomach pain. Stop use and contact doctor immediately.
Is linagliptin safe for kidneys?
Yes, effective and safe in severe renal impairment without dose change.
How to cope with side effects of linagliptin tablets
- Feeling sick (nausea): Take with food; small frequent meals.
- Headache: Rest, hydrate; paracetamol if needed.
- Cold-like symptoms: Rest, fluids; see doctor if worsening.
- Low blood sugar: Consume 15g fast carbs (glucose tabs/juice), recheck in 15 min.
Consult your doctor for persistent issues; do not stop without advice.
Pregnancy and fertility while taking linagliptin tablets
Avoid in pregnancy (Category C); animal studies show no direct harm but limited human data. Effective non-hormonal contraception advised if fertile. Unknown in breast milk—pump and discard or use alternative.
Casualty — urgent treatment needed
Call emergency services for: severe hypoglycemia (unconscious), pancreatitis signs, allergic reactions (swelling/breathing issues), or heart attack symptoms.
Stopping linagliptin tablets
Do not stop abruptly—may worsen blood sugar. Discuss with doctor for alternatives. Gradual switch if needed.
Further information about linagliptin tablets
Your doctor will monitor HbA1c, kidney function, and adjust therapy. Lifestyle changes amplify benefits: Mediterranean diet, 30-min daily walks. Fixed-dose combinations like Trajenta Duo (with metformin) available.
Disclaimer: This information does not replace professional medical advice. Always consult your healthcare provider.
References
- Trajenta | European Medicines Agency (EMA) — European Medicines Agency. 2023-05-15. https://www.ema.europa.eu/en/medicines/human/EPAR/trajenta
- Tradjenta (linagliptin) tablets Label — U.S. Food and Drug Administration. 2012-08-01. https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/201280s005lbl.pdf
- Linagliptin (Tradjenta): Uses & Side Effects — Cleveland Clinic. 2024-01-10. https://my.clevelandclinic.org/health/drugs/19943-linagliptin-tablets
- Tradjenta (linagliptin): Uses, Side Effects, Dosages — GoodRx. 2025-06-20. https://www.goodrx.com/tradjenta/what-is
- Linagliptin: MedlinePlus Drug Information — MedlinePlus (U.S. National Library of Medicine). 2024-11-05. https://medlineplus.gov/druginfo/meds/a611036.html
- Type 2 Diabetes Medication | Tradjenta® (linagliptin) tablets — Boehringer Ingelheim. 2025-03-12. https://patient.boehringer-ingelheim.com/us/products/tradjenta/
Read full bio of medha deb
















